PharmaEssentia Corporation (LUX:261280523)

PharmaEssentia Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20,783	21,051	19,666	10,304	3,454	3,200
Short-Term Investments	-	-	-	-	-	12
Cash & Short-Term Investments	20,783	21,051	19,666	10,304	3,454	3,212
Cash Growth	3.60%	7.04%	90.86%	198.34%	7.51%	130.17%
Accounts Receivable	3,259	2,624	1,312	798.87	466.04	450.6
Other Receivables	158.29	208.01	236.08	41.22	27.17	2.74
Receivables	3,417	2,832	1,548	840.09	493.22	453.34
Inventory	1,171	1,287	1,459	1,102	861.38	394.85
Prepaid Expenses	336.08	163.58	151.92	55.64	49.02	43.95
Other Current Assets	64.4	83.63	71.18	1,074	69.41	42.91
Total Current Assets	25,771	25,417	22,896	13,375	4,927	4,147
Property, Plant & Equipment	3,797	3,361	2,733	1,018	764.93	891.66
Long-Term Investments	501.8	542.44	163.92	43.24	39.22	95.23
Other Intangible Assets	259.96	272.72	267.91	236.88	246.25	220.65
Long-Term Deferred Tax Assets	2,024	1,120	958.46	483.42	-	-
Other Long-Term Assets	450.19	347.95	249.72	176.38	221.13	176.22
Total Assets	32,804	31,062	27,269	15,333	6,198	5,531
Accounts Payable	146.33	126.47	128.88	230.96	176.38	177.07
Accrued Expenses	1,116	1,106	970.52	667.45	405.5	275.37
Short-Term Debt	-	-	21	993.88	20	50
Current Portion of Long-Term Debt	8.69	11.9	12.36	12.14	12.05	6.5
Current Portion of Leases	206.9	180.56	211.85	77.76	78.59	90.27
Current Income Taxes Payable	169.95	-	0.99	-	-	-
Current Unearned Revenue	-	0.23	-	-	-	-
Other Current Liabilities	1,694	1,132	806.49	568.16	719.44	487.5
Total Current Liabilities	3,342	2,557	2,152	2,550	1,412	1,087
Long-Term Debt	47.82	50.81	62.71	74.98	87.09	99.2
Long-Term Leases	681.06	722.16	892.29	410.05	338.51	400.76
Long-Term Deferred Tax Liabilities	74.96	81.32	105.96	8.22	-	-
Other Long-Term Liabilities	103.68	170.21	97.91	143.64	106.3	20.79
Total Liabilities	4,259	3,593	3,321	3,191	1,948	1,611
Common Stock	3,422	3,418	3,403	3,025	2,769	2,634
Additional Paid-In Capital	23,592	23,547	24,092	13,421	4,697	3,727
Retained Earnings	4,296	2,974	-631.19	-4,186	-2,811	-2,144
Treasury Stock	-2,805	-2,805	-2,805	-87.5	-344.74	-257.24
Comprehensive Income & Other	41.75	335.89	-110.37	-31.54	-60.15	-40.44
Shareholders' Equity	28,545	27,469	23,948	12,141	4,250	3,920
Total Liabilities & Equity	32,804	31,062	27,269	15,333	6,198	5,531
Total Debt	944.47	965.43	1,200	1,569	536.24	646.73
Net Cash (Debt)	19,838	20,086	18,466	8,735	2,917	2,566
Net Cash Growth	4.50%	8.77%	111.40%	199.41%	13.71%	164.17%
Net Cash Per Share	59.35	60.13	57.26	30.73	11.21	10.59
Filing Date Shares Outstanding	333.27	332.89	331.36	301.55	273.06	260.48
Total Common Shares Outstanding	333.27	332.89	331.36	301.55	273.06	260.48
Working Capital	22,429	22,860	20,744	10,825	3,515	3,061
Book Value Per Share	85.65	82.52	72.27	40.26	15.57	15.05
Tangible Book Value	28,285	27,196	23,680	11,904	4,004	3,699
Tangible Book Value Per Share	84.87	81.70	71.46	39.48	14.66	14.20
Land	58.24	58.24	58.24	58.24	58.24	58.24
Buildings	69.82	70.86	70.63	70.61	70.52	70.54
Machinery	824.12	811.38	723.26	534.93	486.58	442.21
Construction In Progress	2,471	2,011	1,188	234.56	36.49	42.56
Leasehold Improvements	453.33	429.87	426.29	371.12	341.61	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.